Author | Christopher-Paul Milne

Articles

FDA’s Breakthrough Therapy Designation

September 08, 2015

Pharmaceutical Executive

Article

Three key questions dominate the agency’s Breakthrough Therapy Designation program since its 2012 launch.

Meeting Unmet Medical Needs: The Disparity Dilemma

February 01, 2015

Pharmaceutical Executive

Article

The US drug regulatory system fails to address the country’s most urgent medical needs with the resources appropriate for the task. But change is possible.